ARCHIVED CONTENT
You are viewing ARCHIVED CONTENT released online between 1 April 2010 and 24 August 2018 or content that has been selectively archived and is no longer active. Content in this archive is NOT UPDATED, and links may not function.
By K. Royal
Healthcare companies have long been held to a higher standard when it comes to privacy and now cybersecurity. The relationship privilege enjoyed between a doctor and patient, which dates back to Hippocrates in 400 BC, serves as the first state’s confidentiality of medical information law. Since then, medical confidentiality provisions have only grown in scope and oversight. From Europe to Asia-Pacific to the Americas – and everywhere in between – anywhere that has a privacy law has heightened requirements for health information, typically considered sensitive information.
The United States is somewhat known for not having the data privacy sophistication that many other nations have, but we are seeing growth in privacy oversight in the United States, one of the most recent precedential events occurring through a decision by the US Court of Appeals for the Third Circuit in US Federal Trade Commission (FTC) v. Wyndham Worldwide Corporation.
Read the complete article at: What FTC v. Wyndham Means For You